Author Correction: Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial

Nat Commun. 2026 Feb 27;17(1):2057. doi: 10.1038/s41467-026-70146-3.

Authors

Iddo Weiner¹, Maya Kahan-Hanum², Nufar Buchstab², Lior Zelcbuch², Sharon Navok², Irit Sherman², Julian Nicenboim², Tim Axelrod², Dikla Berko-Ashur², Maya Olshina², Ron Mordoch², Jagoda Jablonska², Tamar Gera-Inbar², Ilya Vainberg-Slutskin², Britny Blumenfeld², Hila Sberro-Livnat², Ayelet Moses², Hadas Nevenzel², Inbal Levy-Saar², Jenia Gold², Meital Goldberg², Nina Tchernorudsky², Noa Ben-Yishay², Tal Cohen², Edith Kario², Inesa Levovich², Roman Safonov², Yaron Tzur², Yulia Zarchin², Vered Lev², Yifat Elharar², Einav Safyon-Gartman², Inbar Gahali-Sass², Sailaja Puttagunta³, Xilla Ussery³, Regis Vilchez³, Urania Rappo³, Naomi Zak², Myriam Golembo², Ariel Cohen², Jon Koff⁴, Eitan Kerem⁵, Rotem Sorek⁶, Merav Bassan²

Affiliations

¹ BiomX Ltd, Ness Ziona, Israel. iddow@biomx.com.
² BiomX Ltd, Ness Ziona, Israel.
³ BiomX Inc, Cambridge, MA, USA.
⁴ Section of Pulmonary, Critical Care, & Sleep Medicine, Center for Phage Biology & Therapy, Yale University, CT, USA.
⁵ Department of Paediatrics and CF Center, Hebrew University Medical School, Hadassah Medical Center, Jerusalem, Israel.
⁶ Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.

No abstract available

Publication types

Published Erratum